Piribedil is an antiparkinsonian agent that acts as a D2 and D3 receptor agonist, primarily used in the management of Parkinson's disease. This piperazine derivative is supported by a comprehensive range… Read more
![Chemical structure of (6-(Benzo[d][1,3]dioxol-5-ylmethyl)benzo[d][1,3]dioxol-5-yl)methanol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F42123-22-8-6-Benzod13dioxol-5-ylmethylbenzod13dioxol-5-ylmethanol.png&w=3840&q=75)
![Chemical structure of 1,1,4-Tris(benzo[d][1,3]dioxol-5-ylmethyl)piperazin-1-ium Chloride](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F114-Trisbenzod13dioxol-5-ylmethylpiperazin-1-ium-Chloride.png&w=3840&q=75)
![Chemical structure of 1,1-Bis(benzo[d][1,3]dioxol-5-ylmethyl)-4-(pyrimidin-2-yl)piperazin-1-ium Chloride](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F11-Bisbenzod13dioxol-5-ylmethyl-4-pyrimidin-2-ylpiperazin-1-ium-Chloride.png&w=3840&q=75)
![Chemical structure of 1,4-bis(Benzo[d][1,3]dioxol-5-ylmethyl)piperazine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F55436-41-4-14-bisBenzod13dioxol-5-ylmethylpiperazine.png&w=3840&q=75)


![Chemical structure of 2-(4-((6-(Benzo[d][1,3]dioxol-5-ylmethyl)benzo[d][1,3]dioxol-5-yl)methyl)piperazin-1-yl)pyrimidine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2-4-6-Benzod13dioxol-5-ylmethylbenzod13dioxol-5-ylmethylpiperazin-1-ylpyrimidine.png&w=3840&q=75)
![Chemical structure of 2-(4-((6-Chlorobenzo[d][1,3]dioxol-5-yl)methyl)piperazin-1-yl)pyrimidine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2-4-6-Chlorobenzod13dioxol-5-ylmethylpiperazin-1-ylpyrimidine.png&w=3840&q=75)
![Chemical structure of 2-(4-(Benzo[d][1,3]dioxol-4-ylmethyl)piperazin-1-yl)pyrimidine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1022849-90-6-2-4-Benzod13dioxol-4-ylmethylpiperazin-1-ylpyrimidine.png&w=3840&q=75)




![Chemical structure of 5,5'-(Oxybis(methylene))bis(benzo[d][1,3]dioxole)](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F109600-72-8-55-Oxybismethylenebisbenzod13dioxole.png&w=3840&q=75)












Piribedil is an antiparkinsonian agent that acts as a D2 and D3 receptor agonist, primarily used in the management of Parkinson's disease. This piperazine derivative is supported by a comprehensive range of reference materials necessary for rigorous pharmaceutical analysis. The selection includes analytical reference standards for the parent drug alongside its known pharmacopeial and non-pharmacopeial impurities, such as oxidized variants, chlorinated derivatives, and various dimers. Laboratories rely on these materials for impurity profiling, allowing for the precise detection and quantification of synthesis byproducts and degradation products. Furthermore, the inclusion of stable isotope labelled compounds provides essential internal standards for mass spectrometry-based assays. These tools are critical for method validation and ongoing quality control, ensuring that testing processes meet established regulatory requirements and providing accuracy in the identification of Piribedil and its related substances.